Rchr
J-GLOBAL ID:200901028370848343   Update date: Aug. 28, 2020

Shibuya Masabumi

シブヤ マサブミ | Shibuya Masabumi
Affiliation and department:
Job title: Others
Other affiliations (2):
  • The University of Tokyo  Professor Emeritus
  • Nagoya University  Others
Research field  (3): Virology ,  Cell biology ,  Molecular biology
Research keywords  (6): 血管生物学 ,  細胞生物学 ,  分子生物学 ,  Vascular Biology ,  Cellular Biology ,  Molecular Biology
Research theme for competitive and other funds  (5):
  • 血管内皮細胞の増殖制御
  • がん関連遺伝子群の構造と機能
  • Analysis of Meiosis and Spermatogenesis
  • Molecular Basis of Endothelial Cell Proliferation
  • Structure and functions of oncogenes and their related genes.
MISC (146):
Books (5):
  • Development of liver vascular system
    Morphogenesis of Endothelium(Harwood Acad. Publ) 2000
  • Structure and function of Flt-1(Vascular Endothelial Growth Factor Receptor-1).
    Current Topics in Microbiology and Immunology 1997
  • A review on the role of VEGF-Flt receptor system in normal and tumor angiogenesis.
    Adv. Cancer Res. 1995
  • Possible involvement of receptor-type tyrosine Kinases EGF-R and FLT in the development of brain tumors.
    Gann Monograph on Cancer Research 1994
  • Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Proceedings of the 24th International Symposium of The Princess Takamatsu Cancer Research Fund. 1994
Education (2):
  • - 1970 The University of Tokyo Faculty of Medicine School of Medicine
  • - 1970 The University of Tokyo Faculty of Medicine
Professional career (2):
  • Ph.D. (The University of Tokyo)
  • 医学博士 (東京大学)
Committee career (3):
  • 1998 - Vascular Medicine学会 会長
  • 1992 - 日本癌学会 評議員
  • 日本ウイルス学会 評議員
Awards (3):
  • 2007 - 高松宮妃癌研究基金・学術賞
  • 2005 - 日本癌学会学術賞吉田富三賞
  • 2005 - Japanese Cancer Association Tomizo-Yoshida Prize
Association Membership(s) (4):
Vascular Medicine学会 ,  日本ウイルス学会 ,  日本分子生物学会 ,  日本癌学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page